Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational Study
ConclusionSemaglutide provided clinically and statistically significant reductions in HbA1c, body weight, lipids and liver enzymes.
Source: Diabetes Therapy - Category: Endocrinology Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Clinical Trials | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Liver | Statistics | Study | Urology & Nephrology | Wales Health | Weight Loss